HealthLynked Corp.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-3.3M | $-6.1M | $-1.0M | $-8.8M | $-10.4M | $-5.8M | $-5.5M | $-5.8M |
| Depreciation & Amortization | $101.9K | $283.0K | $352.0K | $829.5K | $827.7K | $247.4K | $73.4K | $23.8K |
| Depreciation | $101.9K | $115.1K | $123.9K | $113.7K | $106.1K | — | — | — |
| Amortization | $0 | $167.8K | $228.2K | $715.8K | $715.8K | $145.9K | $5.9K | $0 |
| Stock-Based Compensation | $158.6K | $210.3K | $304.0K | $100.0K | — | — | — | — |
| Net Cash from Operating Activities | $-1.7M | $-3.5M | $-4.1M | $-4.4M | $-3.8M | $-2.1M | $-2.4M | $-2.4M |
| Investing Activities | ||||||||
| Capital Expenditures | — | $2.6K | $1.5K | $23.6K | $19.3K | $25.0K | $10.1K | $3.0K |
| Business Acquisitions | — | — | — | $313.8K | — | — | $465.0K | — |
| Net Cash from Investing Activities | $125.0K | $422.4K | $3.5M | $-544.8K | $-341.4K | $1.8M | $-475.1K | $-3.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | $7.7K | — | $1.2K | — |
| Net Cash from Financing Activities | $1.5M | $2.9M | $824.1K | $1.7M | $7.2M | $356.8K | $2.8M | $2.4M |
| Net Change in Cash | — | — | — | $-3.2M | $3.1M | $51.7K | $-25.3K | $85.8K |
| Free Cash Flow | — | $-3.5M | $-4.1M | $-4.4M | $-3.8M | $-2.1M | $-2.4M | $-2.4M |